Latest filings (excl ownership)
No filings
Latest ownership filings
4
ALNYLAM PHARMACEUTICALS, INC.
20 May 24
4
ALNYLAM PHARMACEUTICALS, INC.
29 Dec 23
144
ALNYLAM PHARMACEUTICALS, INC.
27 Dec 23
4
ALNYLAM PHARMACEUTICALS, INC.
4 Aug 23
4
ALNYLAM PHARMACEUTICALS, INC.
19 May 23
4
ALNYLAM PHARMACEUTICALS, INC.
3 Aug 21
4
ALNYLAM PHARMACEUTICALS, INC.
19 Jul 21
4
BRISTOL MYERS SQUIBB CO
1 Jul 21
4
Kaleido Biosciences, Inc.
1 Jul 21
4
BRISTOL MYERS SQUIBB CO
14 Jun 21
4
BRISTOL MYERS SQUIBB CO
4 Jun 21
4
Magenta Therapeutics, Inc.
3 Jun 21
4
BRISTOL MYERS SQUIBB CO
2 Apr 21
4
BRISTOL MYERS SQUIBB CO
3 Feb 21
4
BRISTOL MYERS SQUIBB CO
5 Jan 21
4
BRISTOL MYERS SQUIBB CO
2 Oct 20
4
ALNYLAM PHARMACEUTICALS, INC.
6 Jul 20
4
BRISTOL MYERS SQUIBB CO
2 Jul 20
4
Kaleido Biosciences, Inc.
1 Jul 20
4
BRISTOL MYERS SQUIBB CO
16 Jun 20
4
BRISTOL MYERS SQUIBB CO
9 Jun 20
3/A
BRISTOL MYERS SQUIBB CO
9 Jun 20
4
Magenta Therapeutics, Inc.
9 Jun 20
4
BRISTOL MYERS SQUIBB CO
5 Jun 20
4
BRISTOL MYERS SQUIBB CO
2 Apr 20
4
Sarepta Therapeutics, Inc.
28 Feb 20
5
Magenta Therapeutics, Inc.
14 Feb 20
4
BRISTOL MYERS SQUIBB CO
4 Feb 20
4
BRISTOL MYERS SQUIBB CO
3 Jan 20
3
BRISTOL MYERS SQUIBB CO
27 Nov 19
4/A
BRISTOL MYERS SQUIBB CO
27 Nov 19
4
BRISTOL MYERS SQUIBB CO
22 Nov 19
4
CELGENE CORP /DE/
22 Nov 19
4
Sarepta Therapeutics, Inc.
9 Sep 19
4
ALNYLAM PHARMACEUTICALS, INC.
2 Jul 19
4
CELGENE CORP /DE/
17 Jun 19
4
Syros Pharmaceuticals, Inc.
12 Jun 19
4
Magenta Therapeutics, Inc.
11 Jun 19
4
CELGENE CORP /DE/
5 Jun 19
4
Kaleido Biosciences, Inc.
4 Mar 19